Ligand profile
CHEMBL3981884
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_06703 — Carbepenem-hydrolyzing beta-lactamase KPC2
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL3981884- UniProt (similar protein)
Q93LQ9- pchembl
- 8.100 (~7.9 nM)
- Target protein
- KP13_06703
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 138.4
- −1 ≤ LogP ≤ 5 0.03
- MW ≤ 500 Da 372.4
- LogP ≤ 5 0.03
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 138.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
COc1cc(NC(=O)[C@@H]2CCC3CN2C(=O)N3OS(=O)(=O)O)ccn1COc1cc(NC(=O)[C@@H]2CCC3CN2C(=O)N3OS(=O)(=O)O)ccn1
InChI=1S/C13H16N4O7S/c1-23-11-6-8(4-5-14-11)15-12(18)10-3-2-9-7-16(10)13(19)17(9)24-25(20,21)22/h4-6,9-10H,2-3,7H2,1H3,(H,14,15,18)(H,20,21,22)/t9?,10-/m0/s1InChI=1S/C13H16N4O7S/c1-23-11-6-8(4-5-14-11)15-12(18)10-3-2-9-7-16(10)13(19)17(9)24-25(20,21)22/h4-6,9-10H,2-3,7H2,1H3,(H,14,15,18)(H,20,21,22)/t9?,10-/m0/s1
OVBLFLPUULVQNP-AXDSSHIGSA-NOVBLFLPUULVQNP-AXDSSHIGSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- ChEMBL
- Activity
- 214963.0
- Binding sites
- PF13354
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL3981884 →
- UniProt UniProt Q93LQ9 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL3981884”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_06703.
PDB 36
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).